Pulse Equity: The Healthcare Robots and Gix Internet Aims to Transform Critical Deliveries in Hospitals with AI-Powered Autonomous Systems

HONG KONG, Oct. 20, 2026 /PRNewswire/ -- GIX Internet Ltd. (NASDAQ: GIXI) (TASE: GIX) ("GIX" or the "Company") is an Israeli dual-listed technology company focused on "Physical AI": applying intelligence so that robots, people and goods move more reliably and efficiently in real operating environments. Through its wholly owned subsidiary Deliverz.AI, the Company is developing an AI orchestration platform intended to manage the movement of robots, people and goods within an operational site. The Company views its commercial deployment at Sheba Medical Center as the operational foundation for that strategy.

The platform is designed to act as a central operations system. It assigns tasks in real time based on location, priority and availability, and manages movement from a single interface. Its capabilities include workload prediction, resource planning and route optimization, which are designed to give operators visibility and the ability to shift priorities and direct resources to urgent tasks. The platform is designed to coordinate both robots and human staff, work with robots from different vendors and integrate with a facility's existing elevators, doors, gates and operational systems. This architecture is intended to let customers expand workflows and add compatible robot vendors through a common orchestration layer. The Company offers its solution on a software and robots-as-a-service basis.

The clearest commercial example is at Sheba Medical Center, Israel's largest hospital, which was ranked among the world's top 10 hospitals by The Newsweek Magazine. Deliverz.AI has been operating there commercially since December 2025. According to Company data, in its first major use case (moving chemotherapy medications from the pharmacy to treatment units) the system reduced average delivery time from approximately 40 minutes to approximately 14 minutes, a reduction of approximately 65%, over 11 months. The Company reports more than 9,000 completed autonomous missions across indoor and outdoor routes as of October 2026.

In October 2026, the deployment expanded to additional workflows: transporting bone marrow specimens from the hematology department to the laboratory and moving donated blood from the donation center to the blood bank. These expanded workflows extend the platform's role across additional departments. The Company plans to add further medication and specimen transport routes at the hospital, although there can be no assurance that it will do so. Sheba selected the platform under a public tender that permits the deployment of up to 30 robots, of which 3 robots are currently deployed.

GIX's strategy aims to extend beyond healthcare by creating a single intelligent management layer that can coordinate robots, people and other autonomous systems across complex operational sites. Hospitals are the Company's initial commercial application. The Company believes the platform may have potential applications in manufacturing, logistics, pharmaceuticals, semiconductor facilities, aerospace and automotive operations, although it has not yet commercially deployed in these sectors.

GIX's growth strategy centers on expanding workflows within existing sites, seeking additional commercial deployments, particularly in the U.S., and extending its orchestration software into other sectors. The commercial model combines software and robotics services, which the Company believes may create opportunities for recurring revenue if customers expand their use of the platform. The Company's longer-term objective is for Deliverz.AI to serve as the operating layer for the movement of robots, people and goods within a customer's site, with healthcare providing the foundation for expansion.

Contact:
Pulse Equity
[email protected] 

Paid Promotional Disclosure

This article constitutes a paid promotional communication. GIX Internet Ltd. has engaged Pulse Equity, a brand/division of MR Solutions Limited, to provide investor awareness and promotional services, including the preparation and dissemination of this article, and has paid or for such services.

GIX Internet Ltd. reviewed and approved the content of this article but does not control how, when, or to whom the information is distributed by Pulse Equity.

This article is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of GIX Internet Ltd. Investing in GIX Internet Ltd.'s securities involves significant risks, and readers are encouraged to review GIX Internet Ltd.'s filings with the U.S. Securities and Exchange Commission available at www.sec.gov, and with the Israel Securities Authority available at www.magna.isa.gov.il, before making any investment decision.

Forward-Looking Statements

This article contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws. Forward-looking statements in this article include statements regarding the potential benefits, capabilities and applications of Rail Vision's technologies; their potential role in railway safety, automation and autonomous train operations; the potential expansion of Rail Vision's relationship with Railserve and the entry into definitive agreements; and the potential conversion of existing integrations and pilot projects into larger commercial contracts. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. For a discussion of risks and uncertainties affecting Gix Internet, please refer to Gix Internet's reports filed with the Securities and Exchange Commission ("SEC"), including, but not limited to, the risks detailed in the Company's registration statement on Form 20-F (File No. 001-43362), as amended, as filed with the SEC on June 18, 2026, and in subsequent filings with the SEC. Forward-looking statements speak only as of the date they are made.

Pulse Equity Disclaimer

This article was produced by Pulse Equity, a brand / division of MR Solutions Limited (Hong Kong), and is provided for general informational and promotional purposes only. The content does not constitute investment advice, financial advice, medical advice, or a recommendation to buy, sell, or hold any securities, nor does it constitute an offer or solicitation in any jurisdiction. Pulse Equity is not a registered broker-dealer, investment adviser, securities analyst, or medical professional. The information presented is based on publicly available sources and statements believed to be reliable at the time of publication; however, Pulse Equity makes no representations or warranties as to the accuracy or completeness of the information and has not independently verified all data referenced. 

This article is sponsored and compensated by the company discussed, which may create a conflict of interest.

Readers are encouraged to conduct their own independent research and consult qualified financial, legal, medical, or other professional advisers before making any investment or health-related decisions.

Forward-looking statements referenced in this article are subject to risks and uncertainties, and actual results may differ materially. Past performance is not indicative of future results.

For full disclosures, risk factors, and forward-looking statements, please visit:

https://pulse-equity.com/disclaimer/ 

SOURCE Pulse Equity